EXAGEN INC. (XGN) Social Stream



EXAGEN INC. (XGN): $5.44

-0.33 (-5.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Exagen Inc (XGN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering XGN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-15 5 $33 $24 $27 $8.4 221.43%
2021-11-12 5 $30 $24 $26.25 $8.4 212.5%
2022-01-14 5 $30 $23 $26 $8.4 209.52%
2022-03-24 5 $25 $16 $20 $8.4 138.1%

The Trend in the Analyst Price Target


XGN's average price target has moved down $6.2 over the prior 42 weeks.

Over the past 48 weeks, XGN's average upside potential has been 97.52%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-26 5 33 24 26.60 16.49 61.31%
2021-06-05 5 33 23 26.20 13.33 96.55%
2021-06-16 5 33 23 26.20 16.50 58.79%
2021-07-24 5 33 23 26.20 13.01 101.38%
2021-11-12 5 30 24 26.25 12.87 103.96%

XGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 151 days, XGN's average broker recommendation rating improved by 0.33.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, Exagen Inc's upside potential (average analyst target price relative to current price) is higher than 347.97% of them.
  • In terms of how Exagen Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than 111.88% of that group.
  • In the context of all US stocks, Exagen Inc's average analyst price target is greater than 113.94% of them.
  • In terms of how Exagen Inc fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -29.33% of that group.

In the Healthcare industry, SERA, RNLX, and RDNT are the three stocks most similar to Exagen Inc regarding the price target and analyst recommendation information presented here.

Is XGN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4266 seconds.